Literature DB >> 3957442

Antibody in tears, saliva and nasal secretions following oral immunization of humans with inactivated influenza virus vaccine.

K C Bergmann, R H Waldman, H Tischner, W D Pohl.   

Abstract

Oral immunization of 5 volunteers with an enteric-coated inactivated influenza vaccine resulted in a significant rise of IgA-specific antibodies in tears, saliva and nasal secretion, reaching a maximum response 5-7 weeks after completion of immunization.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3957442     DOI： 10.1159/000234034

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN： 0020-5915


  9 in total

Review 1.  The common mucosal immune system and current strategies for induction of immune responses in external secretions.

Authors:  J Mestecky
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

2.  Oral vaccination with inactivated influenza vaccine induces cross-protective immunity.

Authors:  Fu-Shi Quan; Richard W Compans; Sang-Moo Kang
Journal:  Vaccine       Date:  2011-11-19       Impact factor: 3.641

3.  Influence of ocular surface antigen on the postnatal accumulation of immunoglobulin-containing cells in the rat lacrimal gland.

Authors:  D A Sullivan; L Yee; A S Conner; L E Hann; M Olivier; M R Allansmith
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

Review 4.  Microneedle and mucosal delivery of influenza vaccines.

Authors:  Sang-Moo Kang; Jae-Min Song; Yeu-Chun Kim
Journal:  Expert Rev Vaccines       Date:  2012-05       Impact factor: 5.217

Review 5.  Development of stable influenza vaccine powder formulations: challenges and possibilities.

Authors:  J-P Amorij; A Huckriede; J Wilschut; H W Frijlink; W L J Hinrichs
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

6.  Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine.

Authors:  K S Chen; D B Burlington; G V Quinnan
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

7.  Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus.

Authors:  T Kanesaki; B R Murphy; P L Collins; P L Ogra
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

8.  A novel particulate influenza vaccine induces long-term and broad-based immunity in mice after oral immunization.

Authors:  G T Pang; R L Clancy; S E O'Reilly; A W Cripps
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

Review 9.  Mucosal immunity and tolerance: relevance to vaccine development.

Authors:  C Czerkinsky; F Anjuere; J R McGhee; A George-Chandy; J Holmgren; M P Kieny; K Fujiyashi; J F Mestecky; V Pierrefite-Carle; C Rask; J B Sun
Journal:  Immunol Rev       Date:  1999-08       Impact factor: 12.988
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.